Nieves Martinez Lago, Specialist in the Field (FEA) of Medical Oncology at University Hospital Complex of Santiago de Compostela, shared a post on X:
” Translating biology into therapy in CRC:
- MAPK pathway at the core (RAS ~35%, BRAF ~10%)
- KRAS G12C – anti-EGFR ± ChT
- RAS(ON) inh emerging
- BRAF V600 – multi-level blockade (EGFR/MEK/ERK)
- ADCs, bispecifics, DDR inh
Toward dynamic, multiomic precision oncology.”
Title: Emerging and Established Targets in Colorectal Cancer: Translating Biology Into Therapeutics
Authors: Rafael Grochot, Michela Bartolini, Sandra Algaze, Patrick Reimann, Thomas Winder, Heinz-Josef Lenz, Elisa Fontana
Other articles featuring Nieves Martinez Lago on OncoDaily.
